Xgenomes Corp.
Publicly observedCambridge, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Cambridge | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Xgenomes Corp. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | URQZNV343D65 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: Achieving ultra-high-density, ultra-high-precision single molecule localization microscopy with whole-video deep learning architectures
USD 349,280.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2025Publicly observed
NIH SBIR/STTR award: A novel ctDNA analysis solution for the next-generation of liquid biopsy assays
USD 399,816.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jun 2025Publicly observed
NIH SBIR/STTR award: Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kinetics
USD 397,599.00 · National Human Genome Research Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.